These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 5770018)

  • 1. Multiple substrate determination of monoamine oxidase distribution and iproniazid inhibition in rat brain.
    La Motte RH; Schmidt DE; Ruliffson WS
    J Neurochem; 1969 May; 16(5):725-30. PubMed ID: 5770018
    [No Abstract]   [Full Text] [Related]  

  • 2. Iproniazid inhibition of monoamine oxidase: cytophotometric measurements in various regions of rabbit brain.
    Eadie MJ; Tyrer JH; Kukums JR
    Brain; 1968 Sep; 91(3):519-24. PubMed ID: 5723021
    [No Abstract]   [Full Text] [Related]  

  • 3. The nature of inhibition of cat brain mitochondrial monoamine oxidase by clorgyline.
    Youdim MB; Holman B
    J Neural Transm; 1975; 37(1):11-24. PubMed ID: 1159411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.
    Neff NH; Yang HY
    Life Sci; 1974 Jun; 14(11):2061-74. PubMed ID: 4603266
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative studies on the oxidation of 5-hydroxytryptamine and 3,4-dimethoxyphenylethylamine in rat, dog and human brain.
    Huszti Z; Borsy J
    J Neurochem; 1968 Dec; 15(12):1407-13. PubMed ID: 5729421
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of dexamethasone on monoamine oxidase inhibiton by iproniazid in rat brain.
    Veals JW; Korduba CA; Symchowicz S
    Eur J Pharmacol; 1977 Feb; 41(3):291-9. PubMed ID: 837973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase: multiple forms and selective inhibitors.
    Youdim MB; Collins GG; Sandler M
    Biochem J; 1971 Feb; 121(3):34P-36P. PubMed ID: 4399166
    [No Abstract]   [Full Text] [Related]  

  • 8. Further studies on the inhibition of monoamine oxidase by M & B 9302 (clorgyline). II. Comparison of M & B 9302 inhibition with that of iproniazid.
    Hall DW; Logan BW
    Biochem Pharmacol; 1969 Aug; 18(8):1955-9. PubMed ID: 5811628
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-monoamine-oxidase activity of some beta-acyl-phenylhydrazines].
    Arrigo Reina R; Mazzone G
    Boll Soc Ital Biol Sper; 1970 Dec; 46(24):1041-4. PubMed ID: 5519865
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase activities towards biogenic monoamines in several regions of rat brain.
    Harada M; Kondo Y; Kuzuya H; Nagatsu T
    J Neurochem; 1975 Jan; 24(1):193-5. PubMed ID: 1110362
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum prolactin and brain and pituitary monoamine responses to chronic monoamine oxidase inhibition in the rat.
    Smythe GA; Brandstater JF
    Aust J Biol Sci; 1979 Dec; 32(6):543-7. PubMed ID: 317700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 13. Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine.
    Roth JA; Gillis CN
    Biochem Pharmacol; 1974 Sep; 23(18):2537-45. PubMed ID: 4412708
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
    Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
    Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine oxidase activity in brains from schizophrenic and mentally normal individuals.
    Schwartz MA; Aikens AM; Wyatt RJ
    Psychopharmacologia; 1974; 38(4):319-28. PubMed ID: 4427984
    [No Abstract]   [Full Text] [Related]  

  • 16. Human brain monoamine oxidase: multiple forms and selective inhibitors.
    Youdim MB; Collins GG; Sandler M; Bevan Jones AB; Pare CM; Nicholson WJ
    Nature; 1972 Mar; 236(5344):225-8. PubMed ID: 4553640
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of gamma-aminobutyric acid on brain serotonin and catecholamines.
    Yessaian NH; Armenian AR; Buniatian HC
    J Neurochem; 1969 Oct; 16(10):1425-33. PubMed ID: 5309558
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 19. The chemoarchitectonics in the chiropteran brain.
    Masai H; Ishibashi H
    J Hirnforsch; 1968; 10(3):271-8. PubMed ID: 5732946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synthesis and biological activity of certain thyroxine and adrenergic derivatives. VII. Influence of various iodine phenolic derivatives on guinea pig hepatic monoamine oxidase and on rat cerebral monoamine oxidase].
    Michel R; Truchot R; Autissier N; Rosner B
    Biochem Pharmacol; 1966 Aug; 15(8):1127-38. PubMed ID: 5981989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.